Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 5139651, 11 pages
http://dx.doi.org/10.1155/2016/5139651
Clinical Study

Effect of Xinjiang Uyghur Vernonia anthelmintica Willd Injection Treatment with Silicosis Fibrosis

1Department of Occupational Disease Prevention and Control, The Fifth Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830011, China
2Xinjiang Medical University, Urumqi, Xinjiang 830054, China
3Department of Pathology, The Fifth Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830011, China

Received 12 April 2016; Revised 18 June 2016; Accepted 20 June 2016

Academic Editor: Taiyoun Rhim

Copyright © 2016 Guitao Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Vidaller, G. Sais, F. Mitjavila, J. L. Rodríguez, and J. Peyrí, “Photosensitivity and autoantibodies to Sm, Ro, and La in a patient with silicosis,” International Journal of Dermatology, vol. 35, no. 9, pp. 679–680, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. G. R. Wagner, “Asbestosis and silicosis,” The Lancet, vol. 349, no. 9061, pp. 1311–1315, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Wang, W. Dai, Y. Wang, Q. Gu, D. Yang, and M. Zhang, “Blocking the Wnt/β-catenin pathway by lentivirus-mediated short hairpin RNA targeting β-catenin gene suppresses silica-induced lung fibrosis in mice,” International Journal of Environmental Research and Public Health, vol. 12, no. 9, pp. 10739–10754, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. T. Cox Jr., “An exposure-response threshold for lung diseases and lung cancer caused by crystalline silica,” Risk Analysis, vol. 31, no. 10, pp. 1543–1560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. M. Bang, J. M. Mazurek, J. M. Wood, G. E. White, S. A. Hendricks, and A. Weston, “Silicosis mortality trends and new exposures to respirable crystalline silica—United States, 2001–2010,” Morbidity and Mortality Weekly Report, vol. 64, no. 5, pp. 117–120, 2015. View at Google Scholar · View at Scopus
  6. X. Zhang, L. Zheng, Y. Sun, and X. Zhang, “Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population,” Tumor Biology, vol. 35, no. 2, pp. 1575–1580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Otsuki, H. Sakaguchi, A. Tomokuni et al., “Soluble Fas mRNA is dominantly expressed in cases with silicosis,” Immunology, vol. 94, no. 2, pp. 258–262, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Tzouvelekis, V. Harokopos, T. Paparountas et al., “Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1α in disease pathogenesis,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 11, pp. 1108–1119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Gemoll, U. J. Roblick, G. Auer, H. Jörnvall, and J. K. Habermann, “SELDI-TOF serum proteomics and colorectal cancer: a current overview,” Archives of Physiology and Biochemistry, vol. 116, no. 4-5, pp. 188–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Vormbrock, G. Kaber, S. Hartwig, J. Eckel, K. Schrör, and S. Lehr, “Targeting phosphoprotein profiling by combination of hydroxyapatite-based phosphoprotein enrichment and SELDI-TOF MS,” Archives of Physiology and Biochemistry, vol. 116, no. 4-5, pp. 181–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. I. H. Witten and E. Frank, Data Mining: Practical Machine Learning Tools and Techniques, Morgan Kaufmann, San Francisco, Calif, USA, 2nd edition, 2005.
  12. S. K. Hong, B. K. Chang, S. H. Song, and E.-C. Kim, “Use of MALDI-TOF MS technique for rapid identification of bacteria from positive blood cultures,” Indian Journal of Medical Microbiology, vol. 32, no. 4, pp. 419–422, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Carnesecchi, C. Deffert, Y. Donati et al., “A key role for NOX4 in epithelial cell death during development of lung fibrosis,” Antioxidants and Redox Signaling, vol. 15, no. 3, pp. 607–619, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Richeldi, H. R. Collard, R. M. Du Bois et al., “Mapping the future for pulmonary fibrosis: report from the 17th international colloquium on lung and airway fibrosis,” European Respiratory Journal, vol. 42, no. 1, pp. 230–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Liu, M. Ullenbruch, Y. Y. Choi et al., “Telomerase and telomere length in pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 2, pp. 260–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. I. E. Fernandez and O. Eickelberg, “The impact of TGF-β on lung fibrosis: from targeting to biomarkers,” Proceedings of the American Thoracic Society, vol. 9, no. 3, pp. 111–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-R. Kang, G. L. Chun, R. J. Homer, and J. A. Elias, “Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis,” Journal of Experimental Medicine, vol. 204, no. 5, pp. 1083–1093, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhou, J.-Y. Lee, C.-M. Lee et al., “Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis,” Journal of Biological Chemistry, vol. 287, no. 50, pp. 41991–42000, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. R. Cullinane, C. Yeager, H. Dorward et al., “Dysregulation of galectin-3: implications for Hermansky-Pudlak syndrome pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 3, pp. 605–613, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Wilson, E. Elnekave, M. M. Mentink-Kane et al., “IL-13Rα2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice,” Journal of Clinical Investigation, vol. 117, no. 10, pp. 2941–2951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. L. Foucher, G. F. Späth, and I. K. Pemberton, “Probing the dynamic nature of signalling pathways by IMAC and SELDI-tof MS,” Archives of Physiology and Biochemistry, vol. 116, no. 4-5, pp. 163–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Fröbel, S. Hartwig, W. Paßlack et al., “ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum,” Archives of Physiology and Biochemistry, vol. 116, no. 4-5, pp. 174–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Deniz, S. Gumus, F. Ors et al., “Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in patients with silicosis due to denim sandblasting,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 3, pp. 483–488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Zhu, R. J. Homer, Z. Wang et al., “Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production,” Journal of Clinical Investigation, vol. 103, no. 6, pp. 779–788, 1999. View at Publisher · View at Google Scholar · View at Scopus